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We examined the role of clock genes in the diurnal
regulation of plasma triglyceride-rich apolipoprotein
B-lipoproteins and their biosynthetic chaperone,
microsomal triglyceride transfer protein (MTP).
Clockmt/mtmice showed sustained hypertriglyceride-
mia and high MTP expression. CLOCK knockdown
activated MTP promoter and reduced small hetero-
dimer partner (SHP, NROB2). CLOCK upregulated
SHP by binding to its E box. SHP suppressed MTP
expression by binding to the HNF4a/LRH-1 at the
MTP promoter. Cyclic expression ofMTP after serum
shock was abrogated by siCLOCK and siSHP.
Plasma triglyceride and MTP showed reduced
diurnal variations in Shp/ mice. Whereas peaks
and nadirs in SHP expression were inversely corre-
lated with those of MTP, these changes were
reduced in Clockmt/mtmice. Expression of Shp abro-
gated hypertriglyceridemia in Clockmt/mt mice.
Together, these studies describe a role of Clock/
Shp in the diurnal regulation of MTP and plasma
triglyceride and indicate that disruptions in circadian
regulation might cause hyperlipidemia.
INTRODUCTION
Several biological, physiological, and behavioral activities show
a characteristic recurrence with 24 hr intervals attuned to sunrise
and sunset. Light entrains central clocks present as two lateral
suprachiasmatic nuclei in the hypothalamus via the retinohypo-
thalamic tract. The circadian clock arises from autoregulatory
transcriptional, translational, and posttranslational feedback
loops of few transcription factors known as clock genes,
including circadian locomotor output cycles kaput (Clock), brain
and muscle aryl hydrocarbon receptor nuclear translocator-like
1 (Bmal1), neuronal PAS-containing protein 2 (NPAS2), period
genes (Per1, Per2, and Per3), and cryptochrome genes (Cry1
and Cry2) (Dunlap, 1999; Reppert and Weaver, 2001; Lowrey
and Takahashi, 2004).
Clock/Bmal1 or Npas2/Bmal1 heterodimers bind E box
sequences present in the promoter regions of Per1/2/3 and
Cry1/2 genes and enhance their expression, constituting174 Cell Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Inca positive loop (Gekakis et al., 1998). When concentrations of
Per and Cry proteins increase, they form heterodimers and
suppress transcription of Bmal1, forming a negative feedback
loop (Darlington et al., 1998). Besides this circuitry, circadian
clock signals are transmitted to other clock-controlled genes
via different transcription factors, leading to circadian variations
in various biological and behavioral activities. For example,
Clock/Bmal1 enhance expression of Rev-erba and albumin
D element-binding protein (DBP) that regulate bile acid and
drug metabolisms (Green et al., 2008; Lowrey and Takahashi,
2004; Hussain and Pan, 2009). Rev-erba regulates bile acid
metabolism by regulating CYP7A1 via regulation of repressors
Shp or E4bp4 or by an indirect mechanism involving Insig2
(Duez et al., 2008; Le Martelot et al., 2009). Similarly, DBP is up-
regulated by the binding of Clock/Bmal1 to its E box sequences
(Ripperger et al., 2000). DBP and its homologs play an important
role in drug detoxification (Gachon et al., 2006). In addition to
being a clock-controlled gene, Rev-erba also downregulates
Bmal1 and therefore is also a component of the central clock
genes (Preitner et al., 2002). In contrast to the suppression of
Bmal1 by Rev-erba, ROR transcription factors upregulate
Bmal1; therefore, Rev-erba/ROR/Bmal1 also constitute an
additional regulatory loop that stabilizes the central circadian
loops of Clock/Bmal1/NPAS2 and Crys/Pers (Ueda et al.,
2002; Gachon et al., 2006; Liu et al., 2008).
In addition to suprachiasmatic nuclei, clock and clock-
controlled genes are expressed in other tissues (Sakamoto
et al., 1998; Yamamoto et al., 2004; Lowrey and Takahashi,
2004). Moreover, rhythmic expression of these genes can be
induced in cultured cells after brief exposure to high serum
concentrations (Balsalobre et al., 1998). Thus, several cells are
capable of expressing self-sustained circadian rhythms after
appropriate entrainment. It is believed that the master clock
synchronizes peripheral clocks involving neural connections
and humoral chemicals.
The role ofClock is studied usingClockmutantmice (Clockmt/mt)
that express a dominant-negative protein (Vitaterna et al., 1994;
King et al., 1997). Clockmt/mt are arrhythmic, exhibiting longer
circadian periods and decreased amplitude of locomotors
activity (Vitaterna et al., 1994). These mice show several physio-
logic abnormalities, such as reduced fertility (Miller et al., 2004),
obesity, and the metabolic syndrome (Turek et al., 2005). It is
unclear how expression of a mutant Clock protein causes these
metabolic abnormalities. Moreover, polymorphisms in CLOCK
gene are associated with metabolic syndrome and obesity in
humans (Garaulet andMadrid, 2009), butmolecularmechanisms.
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Clock Controls MTP and Plasma Triglyceride via SHPhave not been elucidated. Our aim was to find out how CLOCK
regulates plasma lipids to gain insights into hyperlipidemia that
might contribute to metabolic syndrome and obesity.
Several studies have shown that plasma triglyceride show
diurnal variations (Seaman et al., 1965; Schlierf and Dorow,
1973; Rudic et al., 2004; Pan and Hussain, 2007; Pan and
Hussain, 2009). Plasma triglyceride show persistent diurnal
rhythmicity in rats fasted for 96 hr (Escobar et al., 1998). The
extent of the increases in triglyceride were, however, lower
than those observed in the fed state. Plasma triglycerides are
carried in apolipoprotein B-lipoproteins. We showed that plasma
triglyceride exhibit diurnal variations due to changes in apoB-
lipoproteins (Pan and Hussain, 2007). However, little is known
about the mechanisms that control diurnal changes in plasma
triglyceride and apoB-lipoproteins.
Biosynthesis of apoB-lipoproteins requires a dedicated
chaperone, microsomal triglyceride transfer protein (MTP),
which transfers lipids in vitro between membranes. Mutations
in the MTTP gene are associated with an absence of plasma
apoB-lipoproteins in abetalipoproteinemia. MTP expression is
regulated at the transcriptional level (Hussain et al., 2008). It is
known that proximal 150 bp sequences in the MTTP promoter
contain several regulatory sites (Hagan et al., 1994). The binding
of HNF4a to the HNF4 site is critical for MTTP expression, as
Hnf4a/ mice do not express MTP (Hayhurst et al., 2001).
HNF1a synergistically activates HNF4a-mediatedMTTP expres-
sion (Sheena et al., 2005). Binding of RXR/PPARs and FOXA2 to
DR1 element enhances, whereas binding of NR2F2 to the same
element reduces, MTTP expression (Kang et al., 2003). Binding
of NR2F1 to DR1 has been suggested to suppress MTTP
expression in undifferentiated intestinal cells (Dai et al., 2010).
SREBP1c decreases expression by interacting with IRE/SRE
elements (Sato et al., 1999). Furthermore, different activators
and repressors modulate MTTP expression. For example,
PGC1a and PGC1b modulate MTTP transcription by interacting
with transcription factors that bind to DR1 element (Wolfrum and
Stoffel, 2006). SHP reduces MTP expression by interacting with
HNF4a and LRH-1 (Hirokane et al., 2004; Huang et al., 2007).
We have shown a correlation between MTP expression and
plasma lipids (Pan and Hussain, 2007). Changes in plasma
lipids/lipoproteins and MTP expression are altered by restricted
feeding and abolished by extended exposure to light (Pan and
Hussain, 2007). We observed that Clock is important for
calorie-restricted food entrainment of intestinal nutrient absorp-
tion and expression of different nutrient transporters (Pan and
Hussain, 2009). These studies led to the hypothesis that visual
cues and clock genesmight play a role in the circadian regulation
of MTP and plasma triglyceride. To test this hypothesis, we
studied changes in plasma lipids and hepatic MTP in wild-type
and Clockmt/mt mice fed ad libitum and subjected to food
entrainment, and we examined mechanisms by which Clock
regulates hepatic MTP and plasma triglyceride.
RESULTS
Clock Is Important for Diurnal Regulation of Plasma
Triglyceride and Hepatic Mtp
Clock is a critical transcription factor controlling circadian
rhythms. To evaluate the role of Clock in regulating plasma lipidsCelandhepaticMTP,weusedClockmt/mt (mutant) and theirwild-type
(Clockwt/wt) siblings. Clock protein and mRNA were high just
before the lights went on (Figure S1A available online).Clockmt/mt
mice expressed low levels of Clock that did not show circadian
variations seen in wild-type mice (Figure S1B). Similarly, expres-
sion of several other clock genes, including Npas2, Bmal1,
Rev-erba, Dbp, and Pers, was repressed inmutant mice (Figures
S1C–S1L). Plasma triglycerides in Clockwt/wt were 2- to 3-fold
higher at 24 hr compared to 12 hr (Figure 1A), owing to changes
in apoB-lipoproteins (Figure 1B). In Clockmt/mt, plasma triglyc-
eride (Figure 1B) did not change. These mice had higher plasma
triglyceride at all times seen normally at night in wild-type mice
due to the absence of nadirs in the day. In contrast to triglyceride,
changes in plasma and apoB-lipoprotein cholesterol were less
prominent (Figures 1C and 1D). MTP activity (Figure 1E), mRNA
(Figure 1F), and protein (Figure 1G) showed diurnal variations in
the Clockwt/wt, but not in Clockmt/mt livers. Overall, these data
indicate that Clock is important for daily regulation of plasma
triglyceride and hepatic Mtp.Clock Is Required for Optimal Food Entrainment
of Plasma Triglyceride and Hepatic Mtp
To understand mechanisms behind high plasma triglyceride in
mutant mice, we studied food intake, hepatic lipoprotein
assembly, and response to food entrainment. Clockmt/mt mice
consumed more food (Figure S2A) and synthesized and
secreted more triglyceride-containing lipoproteins (Figure S2B).
To examine whether shifting mice from unrestricted feeding to
daytime scheduled feeding alters daily changes in plasma
lipids, mice were provided food between 11 AM and 3 PM for
10 days. In Clockwt/wt mice, plasma triglyceride (Figure 2A)
and cholesterol (Figure 2C) were significantly higher at the
time of food availability due to increases in apoB-lipoproteins
(Figures 2B and 2D). The food entrainment response was signif-
icantly reduced in mutant mice (Figures 2A–2D). Expression of
hepatic MTP activity (Figure 2E), mRNA (Figure 2F), and protein
(Figure 2G) was increased at the time of food availability, and
these altered expressions were significantly dampened in
mutant mice. All of the clock genes did respond to food entrain-
ment, and their mRNA levels either increased or decreased at
the time of food availability in wild-type mice (Figures S2C–
S2L). Clock genes did not respond to or responded poorly to
food entrainment in mutant mice. These studies indicate that
food entrainment enhances plasma triglyceride and hepatic
Mtp at the time of food availability and that the optimum
responses require normal Clock expression. Therefore, both
food availability and Clock are important modifiers of MTP
expression.Clock Suppresses MTP Expression in Hepatoma Cells
The above studies inClockmt/mt could represent direct regulation
ofMttp by Clock, or they might represent an accommodation to
the long-term expression of the dominant-negative Clock
protein. To examine the role of CLOCK in MTP regulation in
human cell lines, we reduced its expression using RNAi in
Huh-7 cells. siCLOCK significantly reduced CLOCK mRNA and
protein, increased MTTP mRNA protein and activity, and had
no effect on GAPDH mRNA and protein (Figures 3A and 3B)l Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Inc. 175
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Figure 1. Changes in Plasma Lipids and Hepatic MTP in Mice Fed Chow Ad Libitum
(A–G)Clockmt/mt and their wild-type siblings (Clockwt/wt) were kept in 12 hr light-dark cycle and fed chow at ad libitum. Triglyceride and cholesterol weremeasured
in total plasma (A andC) and apoB-lipoproteins (B and D). Liver samples were used tomeasuredMTP activity (E), mRNA (F), and protein (G). Each time represents
mean ± SD; n = 6. Western blot is representative of n = 3.
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Clock Controls MTP and Plasma Triglyceride via SHPcompared with siCONTROL, indicating that CLOCK is a negative
regulator of MTTP expression.
To explore the role of other clock genes, these cells were
exposed to siRNAs against different clock genes (Figures 3C
and 3D). Not only CLOCK, but also BMAL1 and NPAS2, nega-
tively regulated MTTP (Figures 3C and 3D). On the other hand,
DBP, PER2, and CRY1 had no effect on MTP expression,
whereas REV-ERBa, PER1+CRY1, and PER2+CRY2 positively
regulatedMTTP expression. These studies show that thepositive
loop of the circadian clock negatively regulates MTP expression.
Experiments were then performed to determine whether
MTTP induction involves transcriptional and/or translational
mechanisms. Cycloheximide, a protein translation inhibitor,
and actinomycin D, an mRNA transcription inhibitor, decreased
MTP activity with time (Figure 3E) in both siCONTROL- and
siCLOCK-treated cells. MTTP mRNA remained elevated in
cycloheximide-supplemented siCLOCK-treated cells, indicating
that CLOCK may not require protein synthesis for the transcrip-
tional regulation of MTTP (Figure 3F). As expected, actinomycin
D reduced MTP mRNA with time in siCONTROL cells. In
siCLOCK-treated cells, MTP mRNA levels were not elevated in
the presence of actinomycin D, suggesting that CLOCK might
control MTTP expression involving transcriptional mechanisms.176 Cell Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier IncCLOCK Regulates MTP Using SHP
Attempts were made to determine how CLOCK suppresses
MTTP transcription. Analysis of the MTTP promoter did not
reveal any E box sequences; therefore, we hypothesized that
CLOCK might regulate expression of critical transcription
factor(s) that control MTP expression (Hussain et al., 2008; Dai
et al., 2010). Increased expression of activators or decreased
expression of repressors in siCLOCK-treated cells could explain
higher MTP levels. siCLOCK increased MTP mRNA (Figure 4A)
and had no effect on RXRa (Figure 4A) but decreased PPARa,
PGC-1a, HNF4a, and PGC-1b expression (Figure 4A). As these
activators were not changed or were reduced, we concluded
that CLOCK might not regulate MTP by upregulating activators.
Therefore, we studied changes in MTTP repressors. siCLOCK
reduced SHP mRNA (Figure 4A) and protein (Figure 4B) but
had no effect on NR2F2 mRNA (Figure 4A), indicating that
CLOCK might enhance MTTP expression by suppressing SHP.
CLOCK has been shown to bind to the E box sequences present
in the SHP promoter and regulate its expression (Oiwa et al.,
2007). We confirmed this by performing ChIP using anti-Clock
antibodies (Figure 4C, siCONTROL). We detected significantly
less CLOCK binding to SHP E box after siCLOCK treatment
compared with siCONTROL, implying that CLOCK may directly.
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Figure 2. Changes in Plasma Lipids and Hepatic MTP in Mice Subjected to Food Restriction
(A–G) Clockmt/mt and Clockwt/wt siblings were kept in 12 hr light-dark cycle and fed chow from 11 AM to 3 PM for 10 days. Triglyceride and cholesterol were
measured in total plasma (A and C) and apoB-lipoproteins (B and D). Liver samples were used to measure MTP activity (E), mRNA (F), and protein (G). Each
time point represents mean ± SD; n = 6. Western blotting representative of n = 3.
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Clock Controls MTP and Plasma Triglyceride via SHPupregulate SHP. Therefore, SHP might be a clock-controlled
gene responsible for Clock-mediated MTP regulation.
To evaluate the role of SHP in MTP regulation, Huh-7 cells
were treated with siSHP. This treatment significantly reduced
SHP mRNA (Figure 4D) and protein (Figure 4E) but increased
MTP mRNA (Figure 4D), protein (Figure 4E), and activity
(Figure 4F). siGAPDH had no effect on MTP and SHP mRNA
(Figure 4D). To establish further a relation between SHP and
MTP, we expressed SHP using adenoviruses or plasmids.
Expression of SHP reduced MTP activity, mRNA, and protein
(Figures 4G–4I). These studies indicate that SHP represses
MTP expression, confirming other studies (Hirokane et al.,
2004; Huang et al., 2007).
Attempts were thenmade to understand howSHP suppresses
MTTP expression. SHP has been shown to reduce MTTP
expression by binding to HNF-4a (Hirokane et al., 2004) and
LRH-1 (Huang et al., 2007). Therefore, we studied the binding
of SHP to HNF4a, LRH-1, and HNF-1a transcription factors
associated with their putative binding sites on the MTTP
promoter. Under normal conditions (siCONTROL), anti-SHP
antibodies precipitated sequences occupied by HNF4a,
LRH-1, and HNF1a (Figure 4J). The binding of SHP to the
HNF4a-binding site of the MTTP promoter was significantlyCelreduced in siCLOCK- and siSHP-treated cells (Figure 4J).
Compared to HNF4a, the binding of SHP to LRH-1 and HNF1
sites was decreased to a lesser extent in siCLOCK-treated cells.
These studies indicate that knockdown of CLOCK and SHP
significantly decreases the binding of SHP to the MTTP
promoter. To substantiate the effect of SHP onMTTP promoter,
we used constructs that express luciferase under the control of
a basal MTTP promoter (Dai et al., 2010). Cells were cotrans-
fected with pMTP-205-Luc (expresses firefly luciferase under
the control of 205 bpMTTP promoter),Renilla luciferase (a trans-
fection control), and plasmids expressing either GFP or SHP
(Figure 4K). SHP expression reduced basal MTP promoter
activity by 50%. Conversely, cotransfection of pMTP-204 with
siSHP or siSHP/siCLOCK increased promoter activity
by 4-fold (Figure 4L). These studies indicate that SHP might
suppress MTTP expression by binding to HNF4a and LRH-1.
We posit that CLOCK increases SHP, and enhanced SHP
expression leads to decreased MTP expression.
Cyclic Expression of MTP Is Regulated
by CLOCK and SHP
The above studies indicate that CLOCK regulates MTP expres-
sion by modulating SHP. However, these studies do not affirml Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Inc. 177
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Figure 3. Clock Knockdown Increases MTP Expression
(A and B) Huh-7 cells (n = 3) were treated with siCLOCK or siCONTROL for 72 hr. CLOCK, MTTP, and GAPDH mRNA (A) and protein (B) were determined by
qRT-PCR and immunoblotting, respectively. Changes in mRNA with respect to siCONTROL-treated cells are presented. **p < 0.05, compared to siCONTROL.
(C and D) Huh-7 cells were treatedwith different siRNA for 72 hr. Cells were used tomeasure triglyceride transfer activity (C), protein (inset), andmRNA (D) levels of
MTP.
(E and F) Huh-7 cells (n = 3) were treatedwith siCLOCKor siCONTROL for 72 hr and treatedwith either cycloheximide (20 mM) or actinomycin D (2 mM) for 4 or 12 hr
and were used to measure MTP activity (E) and mRNA (F). *p < 0.5 and **p < 0.05 compared to siCONTROL.
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Clock Controls MTP and Plasma Triglyceride via SHPwhether these genes play a role in the rhythmic expression of
MTP. It is known that brief exposure of cells to 50% horse serum
induces circadian expression of various genes (Balsalobre et al.,
1998). Therefore, HepG2 (Figure S3) and Huh-7 (Figure 5) cells
were incubated in serum-free media for 18 hr, exposed to 50%
serum for 2 hr, washed, and incubated in serum-free media.
MTP mRNA and activity were augmented immediately after
serum supplementation. Subsequently, it showed rhythmic
expression (Figures 5A and 5B). SHP mRNA (Figure 5C) also
showed cyclic expression after 50% serum exposure; however,
it was anti-phasic with MTP. First, there was no induction in SHP
expression soon after serum shock. Second, peak expression of
SHP occurred at times of low MTP expression. GAPDH mRNA
did not change after serum shock and did not exhibit cyclic
expression (Figure 5C). These studies show that serum shock
induces cyclic expression of MTP and SHP. Their expression
exhibits disparate peaks and nadirs.
Next, we explored the role of CLOCK and SHP in the cyclic
regulation of MTTP mRNA by reducing their expression and
then subjecting them to serum shock. Cells treated with
siCONTROL showed high MTP expression soon after serum
supplementation and a subsequent peak at 32–36 hr (Figure 5D).
Expression patterns of MTP and SHP showed slightly different
temporal expression than seen in Figure 5A, probably because
these cells were subjected to transfections. CLOCK itself did
not show significant rhythmic expression and is in concert with
other studies (Balsalobre et al., 1998). Instead, its association
with Bmal1 and transport to the nuclei show rhythmic changes
(Tamaru et al., 2003; Gallego and Virshup, 2007). Again, GAPDH178 Cell Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Incwas resilient to serum shock, and its expression did not change
with time. siCLOCK (Figure 5E) enhanced MTP expression
(compare with Figure 5D) after serum shock and abrogated its
subsequent rhythmic expression. siCLOCK reduced SHP as
before (data not shown) but abolished rhythmic changes in
SHP mRNA (Figure 5E) and protein (Figure 5G), indicating that
CLOCK is needed for the cyclic expression of SHP after serum
shock. Enhanced expression of MTP after serum supplementa-
tion might be secondary to reduced SHP expression. siCLOCK
reduced CLOCK (data not shown), but the residual mRNA did
not change significantly throughout the experiment compared
to 0 time point. Similar to siCLOCK, siSHP also enhanced MTP
expression soon after serum supplementation (Figure 5F).
However, siSHP-treated cells failed to exhibit cyclic expression
of MTTP. Cosinar analysis compared cyclic changes over 48 hr
and indicated a period of 23.7 ± 0.55 and 25.2 ± 1.07 hr for
Mtp and Shp mRNA, respectively (Figures 5D–5F). Comparison
of changes in two successive 24 hr time intervals gave a p value
of 0.003 for both Mtp and Shp, indicating significant cyclic
changes. Similar analyses in siShp- and siClock-treated cells
gave a p value of 0.274 and 0.198, indicating loss of cyclic
change in Mtp expression. These studies indicate that MTP
exhibits a complex response to serum shock involving early
upregulation followed by rhythmic expression. The first imme-
diate response is enhanced when CLOCK and SHP expressions
are reduced, indicating that these proteins dampen serum
response. However, these proteins are required for the subse-
quent cyclic expression of MTP. To gain biochemical insights
into the rhythmic expression of MTP, we studied the temporal.
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Figure 4. SHP Suppresses MTP Expression
(A–C) Huh-7 cells were transfected with siCLOCK or siCONTROL. After 72 hr, mRNA levels of activators and suppressors ofMTTP expression were quantified by
qRT-PCR (A). Data represent percentage of mRNA in siCLOCK-treated cells compared with siCONTROL. SHP and GAPDH protein were detected by immuno-
blotting (B). Cells were subjected to ChIP using anti-Clock antibodies, and immunoprecipitates were used to amplify E box sequences in the SHP promoter (C).
Data are representative of n = 3. #p < 0.5, ##p < 0.01, and **p < 0.05 compared to siCONTROL.
(D) Huh-7 cells were treated with or without siGL2 (siCONTROL), siSHP, or siGAPDH for 72 hr and were used to measure MTP and SHP mRNA. **p < 0.05
compared to siCONTROL.
(E and F) Huh-7 cells were treated with siSHP for 72 hr and used to measure MTP, SHP, and GAPDH protein by immunoblotting (E) andMTP activity (F). **p < 0.05
compared to siCONTROL.
(G) Huh-7 cells were transfected with plasmids expressing human SHP (+Plasmid SHP) or not (Plasmid GFP). MTP activity wasmeasured after 72 hr. **p < 0.05.
(H) Huh-7 cells were infected with adenoviruses expressing green fluorescent protein (Ad:GFP) or mouse SHP (Ad:SHP). After 48 hr, cells were used to detect
MTP, SHP, CLOCK, and GAPDH proteins.
(I) Cells were transfected with indicated plasmids or infected with viruses. After 72 hr, MTP mRNA were quantified by qRT-PCR. **p < 0.05.
(J) Binding of SHP to different cis elements in the MTTP promoter. Cells were treated with siCONTROL, siCLOCK, or siSHP. After 72 hr, cells were subjected to
ChIP using anti-SHP antibodies. Immunoprecipitates were used to amplify sequences corresponding to HNF4, LRH-1, and HNF1 cis elements.
(K) pMTP-204 promoter construct expressing luciferase under the control of basal humanMTTP promoter or pCMV-Renilla luciferase (control vector) were intro-
duced in Huh-7 cells (n = 3). In addition, cells also received a control- (GFP) or SHP-expressing plasmid. Luciferase activities were measured after 72 hr. *p < 0.5.
(L) pMTP-204 promoter construct or pCMV-Renilla luciferase (as a control vector) were transiently transfected in Huh-7 cells (n = 3). In addition, these cells
received siCONTROL, siSHP, or siCLOCK+siSHP. Luciferase activity was measured after 48 hr. ***p < 0.001 compared to siCONTROL.
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Clock Controls MTP and Plasma Triglyceride via SHPbinding of twomajor activators, HNF4a and HNF1a, to theMTTP
promoter. The binding of HNF4a and HNF1a to the MTTP
promoter was low at 16 hr and high at 36 hr (Figure 5H). In
siCLOCK- and siSHP-treated cells, binding of these transcrip-
tion factors was similar at two different times. These data indi-
cate that rhythmic expression of MTP might be related to the
binding of different amounts of HNF4a/HNF1a to their respective
sites on theMTTP promoter. We also evaluated the role of SHP in
the rhythmic expression of MTP (Figure 5I) by performing ChIP
using anti-Shp antibodies and amplifying sequences corre-
sponding to different cis elements. The binding of SHP to
HNF4, HNF1, and LRH-1 sites in the MTTP promoter was high
at 16 hr and low at 36 hr (Figure 5I, siCONTROL). These time-
dependent changes were not evident in siCLOCK- and siSHP-
treated cells. Based on these studies, we posit that rhythmicCelexpression of MTP involves binding of different amounts of
HNF4a and HNF1a to their respective sites and differential asso-
ciation of SHP at the HNF4/HNF1/LRH-1 sites in the MTTP
promoter. At the time of high MTTP expression, its promoter
has more HNF4a and HNF1a associated with it. At the same
time, the amounts of SHP present with HNF4a and LRH-1 are
low. At the time of low expression, the amounts of HNF4a and
HNF1a associated with the MTTP promoter are low. But, at
this time, there are higher amounts of SHP associated with the
MTTP promoter.
Shp Is Important for the Circadian Regulation of Plasma
Triglyceride and Hepatic Mttp
Our studies in Huh-7 cells indicate that SHP plays an important
role in the cyclic expression of MTP. To determine whether Shpl Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Inc. 179
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Figure 5. CLOCK and SHP Regulate Cyclic Expression of MTP in Huh-7 Cells
(A–C) Huh-7 cells were cultured in DMEM containing 10% serum. Confluent monolayers were incubated in serum-free media for 18 hr and for 2 hr in media con-
taining 50% fetal calf serum. Cells were washed and incubated in serum-free media. At indicated times, three wells were harvested to measure MTP activity (A),
mRNA (B), and SHP/GAPDH mRNA (C) in triplicate.
(D–G) Huh-7 cells were transfected with siCONTROL (D), siCLOCK (E), or siSHP (F). After 48 hr, cells were subjected to 2 hr serum shock. At indicated times,
mRNA levels of different genes were measured (D–F). For comparison, mRNA levels were normalized with 18S rRNA, and the values at 0 hr were normalized
to 1. Other values represent fold change compared to 0 hr. Cell lysates were also used to detect SHP and GAPDH protein (G).
(H) Huh-7 cells were treated with different siRNA and subjected to serum shock. Cells were harvested at 0, 16, and 36 hr and subjected to ChIP assays using anti-
HNF4a or anti-HNF1a antibodies. Immunoprecipitates were used to amplify HNF4 or HNF1 sites in the MTTP promoter.
(I) Huh-7 cells were treated with siRNA and subjected to serum shock. Cells were harvested at 0, 16, and 36 hr and used for ChIP assays using anti-SHP anti-
bodies. The extracted DNAs from the immunoprecipitates were amplified using primers specific for human HNF4, HNF1, and LRH-1 sites in theMTTP promoter.
Data are representative of n = 3.
Cell Metabolism
Clock Controls MTP and Plasma Triglyceride via SHPis essential for the circadian regulation of Mtp and plasma
triglyceride in vivo, we studied their regulation in Shp/ and
Shp+/+ mice (Figure 6). As before, plasma triglyceride showed
diurnal variations in Shp+/+ mice, with higher levels at night
(Figure 6A) owing to changes in apoB-lipoproteins
(Figure 6B). In Shp/ mice, plasma triglyceride did not show
significant variations within 24 hr and exhibited sustained hy-
pertriglyceridemia (Figures 6A and 6B) similar to that seen in
Clockmt/mt mice. Moreover, Shp/ mice had high plasma
apoB100 and apoB48 (Figure S4), absorbed more lipids
(Figure S4B), and consumed more food (Figure S4C). Hepatic180 Cell Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Inctriglyceride and cholesterol levels were similar in wild-type
and knockout mice (Figures S4D–S4E). In Shp+/+ livers, MTP
activity, protein, and mRNA (Figures 6C–6E) showed diurnal
variations with high levels seen at night. In Shp/ liver,
however, Mtp did not show significant variations during 24 hr,
and they remained high at all times (Figures 6C–6E). The
expression profile of Mttp in Shp/ was similar to that in
Clockmt/mt. Therefore, consideration was given to the possibility
that Shp might regulate Mttp involving clock genes. Many clock
genes exhibited similar or reduced amplitudes in Shp/ mice
compared with Shp+/+ mice, except for Rev-erba and Dbp,.
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Figure 6. Plasma Triglyceride and Hepatic Mtp Do Not Change in Shp/ Mice
(A–E) Shp/ and control (Shp+/+) mice were kept in 12 hr light-dark cycle and fed chow ad libitum. Triglycerides were measured in total (A) and apoB-lipoproteins
(B). Liver samples were used to measured Mtp activity (C), mRNA (D), and protein (E). Each time point represents mean ± SD; n = 4–6.
(F and G) Livers were collected at indicated times from male C57BL/6J mice fed ad libitum and used to measure Shp and Gapdh protein (F) and Shp mRNA (G).
They were plotted as line graphs and error bars, respectively. Mean ± SD; n = 6.
Cell Metabolism
Clock Controls MTP and Plasma Triglyceride via SHPwhich showed a significant shift in their rhythmic expression
(data not shown). Certainly, their expression and diurnal varia-
tions were not as dampened as in Clockmt/mt mice (Figure S1).
These studies indicate that Shp expression is important for the
diurnal regulation of plasma triglyceride and hepatic Mttp, but
not for clock genes.CelCircadian Regulation of Shp in Clockwt/wt and Clockmt/mt
Siblings
The studies described so far indicated that plasma triglyceride
and hepatic Mtp profiles are similar in Shp/ and Clockmt/mt
mice. Furthermore, cell culture experiments indicate that CLOCK
might regulate MTP via SHP. If SHP is the clock-controlled genel Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Inc. 181
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Figure 7. Circadian Regulation of Shp and Effect of SHP Expression in Clockwt/wt and Clockmt/mt Siblings
(A and B) Livers were collected at indicated times from male Clockmt/mt and Clockwt/wt siblings fed chow ad libitum to measure Shp/Gapdh protein (A) and Shp
mRNA (B). Each time point for mRNA represents mean ± SD; n = 6.
(C and D) Expression of Shp/Gapdh protein (C) and mRNA (D) in male Clockmt/mt and Clockwt/wt mice kept in 12 hr light-dark cycle and fed chow from 11 AM to
3 PM for 10 days; n = 6.
(E) Binding of Clock to the mouse Shp promoter in Clockmt/mt and Clockwt/wt was studied by ChIP. Livers collected at different times were immunoprecipitated
using anti-CLOCK antibodies and used to amplify E box sequences present in the Shp promoter. Representative electrophoresis image of the PCR products of
clock binding (anti-Clock) and input is shown. This gel is a representative of n = 3.
(F–I) Clockmt/mt mice were injected with Ad-GFP or Ad-mShp (1 3 1011 virus particles/mouse). Plasma and liver were collected after 72 hr at 12:00 or 24:00 hr.
Triglycerides were measured in total plasma and apoB-lipoproteins (F). Plasma was used to detect apolipoproteins by western blotting (G). Liver samples were
used to measure Mtp mRNA and Gapdh mRNA (H) and Mtp protein (I). Each time point for mRNA represents mean ± SD; n = 3. *p < 0.05 compared to Ad-GFP at
12 hr.
(J) A schematic diagram suggesting that external stimuli such as food and light regulate cellular Clock. Clock regulates Shp, and Shp transmits this signal to Mtp.
Changes in Mtp contribute to diurnal variations in plasma triglyceride.
Cell Metabolism
Clock Controls MTP and Plasma Triglyceride via SHPthat suppressesMTTP, then it should show circadian rhythm out
of sync with MTP. Tissue analyses showed that hepatic Shp
expression in C57BL/6J was high in the day compared to the
night (Figures 6F and 6G). Note that MTP expression is low at
this time (Figures 1E–1G and 6C–6E). Shp mRNA and protein
showed rhythmic expression in the livers of Clockwt/wt, but not
in Clockmt/mt siblings (Figures 7A and 7B). The expression of
Shp in Clockmt/mt mice was significantly low compared to that
seen in their wild-type siblings (Figures 7A and 7B). Food entrain-
ment studies revealed that Shp levels were reduced at the time of
food availability in Clockwt/wt, but not in Clockmt/mt mice (Figures
7C and 7D). These studies indicate that Shp shows daily varia-
tions, with peak expressions occurring in the day when Mtp
expression is low. Food entrainment reduces Shp while
enhancing Mtp expression. Therefore, Mtp and Shp show anti-
phasic expression profiles in wild-type mice fed ad libitum or
subjected to food entrainment. However, similar to Mtp, Shp
does not show daily variations in Clockmt/mt mice. In addition,182 Cell Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Incwe examined the association of Clock with the E box of Shp
in vivo by ChIP. The binding of Clock to Shp E box sequences
was high during 4 to 12 AM (Figure 7E), coincident with its high
expression. In Clockmt/mt, the binding of Clock to Shp promoter
was low and did not show rhythmic change within 24 hr
(Figure 7E). These data imply that the binding of Clock to Shp
promoter is associated with increases in its expression.
Expression of SHP in Clockmt/mt Mice Abrogates
Hypertriglyceridemia
The above studies indicated that Shp expression is low in
Clockmt/mt and that it might contribute to high hepatic Mtp
expression and hypertriglyceridemia. We then hypothesized
that expression of SHP would decrease MTP expression and
plasma triglyceride. Indeed, Shp expression significantly
reduced triglyceride in plasma and apoB-lipoproteins
(Figure 7F), plasma apoB100 and apoB48 (Figure 7G), and
hepatic Mtp mRNA (Figure 7H) and protein (Figure 7I) without.
Cell Metabolism
Clock Controls MTP and Plasma Triglyceride via SHPaffecting GAPDH expression (Figures 7H and 7I). These studies
show that Shp decreases Mtp expression and ameliorates hy-
pertriglyceridemia.
DISCUSSION
These studies provide evidence that Clock plays an important
role in the circadian and food entrained regulation of hepatic
Mttp expression and plasma triglyceride. We further show that
CLOCK regulates MTP involving SHP (Figure 7J). CLOCK
temporally interacts with the E box and increases SHP expres-
sion, whereas SHP reduces MTTP expression by differentially
interacting with HNF4a and LRH-1. Decreased interaction of
SHPwith these transcription factors is associatedwith increased
MTTP expression. Therefore, Shp is a clock-controlled gene that
transmits information from Clock to Mttp (Figure 7J).
In Clockmt/mt mice, we found that smaller amounts of Clock
bind to the Shp promoter, and this binding does not fluctuate
within a day. Moreover, this binding leads to low Shp expression
and consequently high Mttp expression at all times and
sustained hypertriglyceridemia similar to that seen at night in
Clockwt/wt mice. The major effect of the Clock mutant protein is
that reductions in the Mttp expression seen in Clockwt/wt mice
at dawn are absent in Clockmt/mt mice.
CLOCK and Other Circadian Genes in the Regulation
of MTP and Plasma Triglyceride
Clockmt/mt mice and Huh-7 cells exposed to siCLOCK express
more MTTP, indicating that Clockmt/mt mice have low Clock
activity. These results are consistent with the observations that
Clock plays an important role in the circadian regulation of liver
and lung rhythms (DeBruyne et al., 2007). In addition to CLOCK,
our cell culture studies indicate that BMAL1 and NPAS2 play
similar roles in MTTP regulation, indicating that the positive
loop of the circadian oscillators is important in reducing MTTP
expression away from feeding times. In contrast, knockdown
of the members of the negative circadian loop had no effect or
reduced MTTP expression. It remains to be determined whether
PERs and CRYs act directly on theMTTP promoter or reductions
in Mttp expression after their knockdown is indirectly delivered
via increased expression and activity of Clock/Bmal1.
Diurnal Regulation of SHP by CLOCK
SHP is a key transcriptional regulator of genes involved in diverse
metabolic pathways and physiological functions (Chanda et al.,
2008). Oiwa and associates observed rhythmic expression of
Shp in the mouse liver (Oiwa et al., 2007) and demonstrated
that Clock/Bmal1, along with Lrh-1, synergistically activate
Shp promoter in vitro, and this activation is suppressed by Shp
itself. They also showed that Clock binds to E box elements
present in the Shp promoter. Here, we confirmed that Shp is
rhythmically expressed in the liver (Figure 6). Moreover, we
showed that the binding of Clock to the E box in the Shp
promoter is high in the day. The rhythmic binding of Clock to
the Shp promoter was synchronous with mRNA and protein
accumulation during daytime in the mouse liver. In Clockmt/mt
mice, however, the binding of Clock to Shp promoter did not
show cyclic change, and Shp mRNA levels were relatively low
(Figure 7). Similarly, levels of Per mRNA are low in Clockmt/mtCel(Figure S1). We propose that Shp is directly regulated by Clock,
similar to Per proteins.
SHP expression did not change soon after serum supplemen-
tation in Huh-7 cells (Figure 5), indicating that it is not a serum-
response gene. Later on, SHP displayed cyclic expression.
The rhythmic expression of SHPwas absent in siCLOCK-treated
cells, pointing to a critical role of CLOCK. In siCLOCK-treated
cells, low levels of CLOCK might not be sufficient to support
cyclic induction of SHP transcription. This interpretation is
consistent with an earlier conclusion that diurnal regulation of
SHP is positively related with increased association of CLOCK
with the SHP promoter. Although these studies indicate that
changes in the association of CLOCK with SHP promoter regu-
late SHP expression, we did not observe comparable changes
in CLOCK transcription, consistent with several studies (Mehra
et al., 2009; Gallego and Virshup, 2007). Therefore, increased
association of CLOCK with the SHP promoter is probably not
a direct consequence of increased amounts of CLOCK. Instead,
posttranslational modifications and its association with BMAL1
might determine enhanced association and subsequent dissoci-
ation of CLOCK from the SHP promoter (Mehra et al., 2009; Gal-
lego and Virshup, 2007).
Shp is negatively regulated by Rev-erba (Duez et al., 2008).
Hence, we hypothesized that Rev-erba would upregulate MTP
expression. This is supported by several observations: siRev-
erba decreases Mtp expression in Huh-7 cells (Figure 3C and
3D);Clockmt/mtmice that have highMTP levels express low levels
of Rev-erba (Figures 1E–1G and S1); and neither Mtp nor Rev-
erba show temporal changes in Clockmt/mt mice (Figures 1E–1G
and S1). Next, we theorized that, if Rev-erba is directly involved
in negative regulation of MTP, then their temporal expression
would be anti-phasic, as we had seen between Mtp and Shp
(Figure 7J). Instead, we found that both Rev-erba and Mtp
show peak expression at similar times. Therefore, it is likely that
Rev-erba indirectly regulates MTP via Shp. We propose that
both the positive and negative loops of the circadian clock are
involved in the diurnal regulation of MTP (Figure S5). Clock/
Bmal1/Npas2 enhance Shp expression and reduceMTP expres-
sion in the daytime. High levels of Rev-erba expression at night
might suppress Shp expression and enhance Mtp expression.
Mechanisms Controlling Cyclic Expression
of MTP in Liver Cells
Many studies have identified several transcription factors that
regulate MTP expression (Hussain et al., 2008). Here, we recog-
nized mechanisms that could contribute to rhythmic expression
ofMTP. First, our studies suggest that cyclic expression ofMTTP
involves differential association of HNF4a and HNF1a to its
promoter. The bindings of these transcription factors to the
promoter were high at the time of maximum MTTP expression.
These transcription factors are known to synergistically activate
MTTP expression (Sheena et al., 2005).
Second, binding of SHP to the MTTP promoter occurs in
rhythmic fashion. At the time of high MTTP expression, lower
amounts of SHP were found associated with HNF4a and LRH-1.
In contrast, higher amounts of SHPwerewith theMTTPpromoter,
coincident with optimal SHP expression. Therefore, MTTP
expression might be directly related to SHP levels. This was
confirmed by overexpressing and reducing SHP. As discussedl Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Inc. 183
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Clock Controls MTP and Plasma Triglyceride via SHPabove,ShpmRNA levels are high at the timeof higher E box occu-
pancy by theClock inmice. Therefore, increased binding of Clock
might lead to enhanced Shp expression. High Shp levels facilitate
its association with MTP promoter causing repression.
Third, the rhythmic binding of HNF4a and HNF1a to the MTTP
promoter was not seen in siCLOCK-treated cells (Figure 5H),
indicating that CLOCK might also play a role in the association
of HNF4a with the MTTP promoter. How CLOCK modulates
the cyclic bindings of HNF4a and HNF1a to theMTTP promoter
remains unknown. Under normal conditions, HNF4a expression
shows no cyclic change (data not shown and Oiwa et al., 2007).
Therefore, increased association of HNF4a with the MTTP
promoter might involve posttranslational mechanisms such as
differential binding of its ligands.Regulation of Plasma Triglyceride
Metabolic syndrome and obesity are major metabolic disorders
characterized by high plasma lipid concentrations. Plasma lipids
are tightly controlled by mechanisms regulating their production
and clearance. Here, we show that light-entrained mechanisms
involving clock genes also play a role in regulating plasma triglyc-
eride.Wedemonstrate that Clock regulates circadian expression
of Mtp by controlling Shp in mice. Changes in Mtp are correlated
with changes in plasma triglyceride, indicating that circadian
changes inMtpcould contribute to changes in plasmaapoB-lipo-
proteins and triglyceride. It is known that hepatic Mtp deficiency
significantly lowers plasma triglyceride (Bjo¨rkegren et al., 2002),
and plasma triglycerides are very low in abetalipoproteinemia
(Berriot-Varoqueaux et al., 2000). InClockmt/mtmice, theamounts
of plasma triglyceride were similar to those seen in Clockwt/wt
siblings at night, suggesting that nadirs seen in wild-type mice
at dawn are absent in these mice. Most likely, Clock plays
a role in the nadirs seen in plasma triglyceride.
Triglyceride transfer activity of MTP has been exploited to
identify several potent antagonists, which inhibit triglyceride
transfer activity in vitro, suppress lipoprotein assembly and
secretion in vivo, and decrease plasma lipids in humans and
animals (Hussain et al., 2008). These drugs show several adverse
effects. Dosing MTP inhibitors away from food intake diminishes
intestinal distress. Based on the daily changes reported here for
MTP, it might be interesting to evaluate the time of dosing on the
pharmacokinetics of drug availability and efficacy, as well as in
avoiding adverse effects.
In short, this study establishes a molecular link between
circadian physiology and plasma lipid metabolism. These
studies suggest that CLOCK regulates MTP expression using
SHP. Although it is possible that other unidentified mechanisms
might be involved, these studies point to the importance of both
CLOCK and SHP in the circadian regulation of MTP and plasma
triglyceride. Aberrations in the clock genes, as inClockmt/mt, lead
to sustained hypertriglyceridemia because changes associated
with dawn, such as upregulation of Shp, downregulation of
Mttp, and reductions in plasma triglyceride, are absent.EXPERIMENTAL PROCEDURES
Animals
Male 8- to 12-week-old C57BL/6Jmice (Jackson Laboratory) weremaintained
in a 12 hr light/dark (LD) cycle (light on 7 AM to 7 PM) with free access to food184 Cell Metabolism 12, 174–186, August 4, 2010 ª2010 Elsevier Incand water. Heterozygous clock mutant breeding pairs (C57BL/6J-Clockm1Jt/J,
Jackson Laboratory, Stock No. 002923) were bred at Downstate Medical
Center. Shp+/+ and Shp/mice on a C57BL/6J background were maintained
at the University of Utah. Male Clockmt/mtmice and their Clockwt/wt siblings, as
well as Shp+/+ and Shp/ mice, were housed under a 12 hr light/dark cycle.
Dissected tissues were quickly frozen and stored at –80C. The Animal Care
Committees at SUNY Downstate Medical Center and the University of Utah
approved animal protocols.
Plasma Lipid Measurements
Total triglyceride and cholesterol weremeasured using kits (ThermoTrace Ltd).
Lipids in high-density lipoproteins were measured after precipitating apoB
lipoproteins. ApoB lipoprotein lipids were determined by subtracting HDL
lipids from total lipid levels (Pan and Hussain, 2007).
Measuring MTP Activity
Livers (100 mg) from different mice were homogenized in 1 ml of buffer K
(1.0 mM EGTA, 1 mM Tris-HCl, and mM MgCl2) and centrifuged at
50,000 rpm for 1 hr. The supernatant was used to measure MTP activity using
a kit (Chylos Inc.) as described (Athar et al., 2004).
RNA Extraction and Real-Time PCR Analysis
Total RNA was isolated from cells and tissues using Trizol reagent. Isolated
RNA was reverse transcribed, and their levels were quantified by SYBR Green
using an ABI Prism 7000 (Applied Biosystems). The primers used to measure
different transcripts have been described (Pan et al., 2007; Pan and Hussain,
2007) and are shown in Table S1.
Small RNA Interference
siRNA directed against different clock genes and nonspecific control siRNA
were obtained from Santa Cruz. They were introduced into Huh-7 cells plated
in 12-well plates using siRNA transfection reagent (SC-29528, Santa Cruz).
After 72 hr, cells were harvested for RNA or protein analysis.
Serum Shock
Huh-7 cells were grown to confluence in high-glucose Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS).
Cells were starved in the same medium with no FBS for 18 hr, 50% horse
serum was added for 2 hr, and then the medium was changed back to starva-
tion medium (Balsalobre et al., 1998). Cells were harvested at 4 hr intervals for
analyses.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation assay (ChIP) was performed according to the
instructions (USB CHIP assay kit #78460) using goat polyclonal antibodies
against CLOCK or SHP from Santa Cruz. DNA samples recovered after immu-
noprecipitation were subjected to PCR using primers previously described
(Huang et al., 2007; Dai et al., 2010) and shown in Table S1. As negative
controls, ChIP was performed in the absence of antibody or in the presence
of rabbit IgG. These experiments were repeated three to four times with similar
results. Data from a representative experiment are provided.
Plasmid Expression and Luciferase Assay
SHP expression using plasmids and adenoviruses has been described (Huang
et al., 2007). Plasmid pMTP204 expressing a 204 kb MTTP promoter was
described (Dai et al., 2010). Huh-7 cells were transfected with either the
pMTP204 construct or empty vector along with a reporter Renilla luciferase
construct and were assayed using the dual luciferase reporter assay system.
Statistical Analyses
Values are expressed as mean ± SD. One-way ANOVA was applied followed
by Dunnett’s two-tailed test or a t test. Cosinar analysis was performed using
a program from http://www.circadian.org/softwar.html.
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